China News
-
Ventana gets CFDA nod for cancer antibody assay
China | News | By BioSpectrum Bureau | 0 Comment | 12 Sep, 2013
Singapore: Ventana Medical Systems, which is a member of the Roche Group, received approval for its Ventana ALK (D5F3) Rabbit Monoclonal Primary Antibody assay by the Chinese Food and Drug ...Read more
-
ShangPharma appoints committee chairman
China | News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2012
Singapore: ShangPharma, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, has appointed Mr Yuk Lam Lo as the chairman of the independent c...Read more
-
BGI study gives insight into human gut microbiota
China | News | By BioSpectrum Bureau | 0 Comment | 27 Sep, 2012
Singapore: A novel metagenomic study on human gut microbiota and their potential impact on type 2 diabetes, the most common form of diabetes, has been published by a team of BGI researchers...Read more
-
China | Influencers | By BioSpectrum Bureau | 0 Comment | 27 Nov, 2012
Singapore: Mr Abraham (Barry) E Cohen, member of BioTime's board of directors, passed away at the age of 76. BioTime is a US-based company, focused on biomedical research and product develo...Read more
-
Dehaier develops portable oxygen inhaler
China | News | By BioSpectrum Bureau | 0 Comment | 15 Jun, 2012
Singapore: Dehaier Medical Systems, an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, has co-developed "High-Eff...Read more
-
China SFDA drug lab gets WHO prequalification
China | Regulatory | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2013
Singapore: The World Health Organization (WHO) has included China's National Institutes for Food and Drug Control (NIFDC) to the list of prequalified quality control laboratories. This in...Read more
-
APAC stem cell therapy market to reach $972mn in 2018
China | News | By BioSpectrum Bureau | 0 Comment | 01 Jan, 2013
Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will grow in value from $545 million in 2012 to $972 million in 2018, at a c...Read more
-
BGI-Shenzhen gets clearnace from NDRC for BGI's acquisition
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: BGI-Shenzhen and Complete Genomics have obtained clearance from the National Development and Reform Commission of the People's Republic of China regarding BGI's proposed acquisi...Read more
-
GSK CEO accompanies UK PM on China visit
China | News | By BioSpectrum Bureau | 0 Comment | 02 Dec, 2013
Singapore: After facing a storm of controversy in China, Sir (Dr) Andrew Witty, CEO, GlaxoSmithKline (GSK) visited the country accompanying UK Prime Minister Mr David Cameron on his trade m...Read more
-
How Chinese economy will impact its life sciences?
China | Opinion | By BioSpectrum Bureau | 0 Comment | 13 Mar, 2013
During a January 2013 economic forum in Beijing, Lou Jiwei, chairman of the China Investment Corporation (CIC), presented forecasts that China's economy could grow at more than eight percen...Read more
-
ShangPharma completes in-house merger
China | News | By BioSpectrum Bureau | 0 Comment | 28 Mar, 2013
Singapore: ShangPharma, a leading China-based pharmaceutical and biotechnology R&D outsourcing company, has completed the merger contemplated by the previously announced agreement and p...Read more
-
China CRO facility undergoes US FDA inspection
China | News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2013
Singapore: For the first time, the US FDA has completed an inspection in China under its combined clinical trial and bioresearch monitoring program. Frontage Laboratories, a pharmaceutical...Read more
-
Why does NYSE want to delist China Botanic?
China | News | By BioSpectrum Bureau | 0 Comment | 06 Feb, 2013
Singapore: China Botanic Pharmaceutical received a notice of failure to satisfy continued listing standards from the New York Stock Exchange (NYSE) stock exchange. NYSE had previously warne...Read more
-
China's national vaccine production base takes safety enhancement measures
China | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2014
Singapore: UK based UV disinfection specialist Hanovia has supplied three UV water disinfection systems, PharmaLine PQL, to the Institute of Medical Biology of Chinese Academy of Sciences i...Read more
-
Mindray to acquire ZONARE Medical Systems
China | News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2013
Singapore: Mindray Medical International has announced a definitive agreement to acquire ZONARE Medical Systems (Zonare), an ultrasound technology leader in the high-end radiology segment, ...Read more
-
Is China bioscience really slowing down?
China | Opinion | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2013
Is China bioscience slowing down? From the numbers that have been put together by the BioSpectrum Asia Pacific Bioscience Industry Survey 2013, it does look so. However, a little deeper loo...Read more
-
US-based TriReme looks for big growth in Asia
China | Influencers | By BioSpectrum Bureau | 0 Comment | 31 May, 2012
TriReme Medical, a US-based start-up medical devices company dedicated to the development and manufacturing of innovative devices for the treatment of complex vascular disease, recently ope...Read more
-
Pharma Logistics China from October 23
China | News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2012
Singapore: The 2nd Pharma Logistics China 2012 will be held from October 23 till October 25 at Shanghai, China. The conference is the foremost and only gathering of heads from leading biot...Read more
